Zydus Wellness · NSE: ZYDUSWELL · BSE: 531335
Q2 FY26 results · Jul–Sep 2025
Zydus Wellness reported revenue from operations of ₹650.50 crore (up 32.0% from Q2 FY25) and net loss of ₹52.80 crore for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 650.50 | 492.90 | +32.0% | 860.90 | −24.4% |
| Other income | 1.40 | 4.00 | −65.0% | 3.00 | −53.3% |
| Total income | 651.90 | 496.90 | +31.2% | 863.90 | −24.5% |
| Profit before tax | (50.60) | 23.70 | Turned loss | 145.30 | Turned loss |
| Net profit for the period | (52.80) | 20.90 | Turned loss | 127.90 | Turned loss |
| EPS, basic (₹) | (1.66) | 3.28 | not comparable | 20.10 | not comparable |
| Net margin (%) | -8.1 | 4.2 | 14.9 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 156.00 | 63.30 | +146.4% | 87.70 | +77.9% |
| Other income | 2.00 | 4.10 | −51.2% | 0.40 | +400.0% |
| Total income | 158.00 | 67.40 | +134.4% | 88.10 | +79.3% |
| Profit before tax | 11.50 | 10.50 | +9.5% | 9.50 | +21.1% |
| Net profit for the period | 7.60 | 8.00 | −5.0% | 7.00 | +8.6% |
| EPS, basic (₹) | 0.24 | 1.26 | not comparable | 1.10 | not comparable |
| Net margin (%) | 4.9 | 12.6 | 8.0 |
Consolidated
- Filed with BSE
- 05 Nov 2025, 18:55 IST
- Board meeting
- 05 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 05 Nov 2025, 18:55 IST
- Board meeting
- 05 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE